Minima Pro Stent System
Renata Medical, Inc. · Decision date Jul 9, 2026
What did the FDA approve?
FDA records P240003/S006 as a supplement to PMA P240003, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 9, 2026.
FDA approval order statement
Approval for design modifications and a line extension to the Minima Stent System, including a stent design change from closed cell to hybrid open-cell, a new 10mm balloon size for expansion of the stent, delivery system design changes, and packaging design changes. The device, as modified, will be marketed under the trade name Minima Pro Stent System.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Cardiovascular
- Decision date
- Jul 9, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P240003/S006
- Regulatory pathway
- PMA supplement
- Applicant
- Renata Medical, Inc.
- Product code
- PNF
- Decision code
- APPR
- Decision date
- Jul 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Aortic stent.
- Applicant
- Renata Medical, Inc.
- Product code
- PNF
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P240003/S004 · Related supplement
Minima Stent System
P240003/S005 · Related supplement
Minima Stent System
P240003/S006 received
Application receipt date recorded by FDA.
P240003/S007 · Related supplement
Minima Stent System
P240003/S006 · FDA decision
Normal 180 Day Track
P240003/S008 · Related supplement
Minima Stent System; Minima Pro Stent System
Timeline entries are records held by MedtechLedger for P240003. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P240003
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Minima Stent SystemP240003/S004 | Renata Medical, Inc. | PMA supplement | Sep 11, 2025 | FDA |
Minima Stent SystemP240003/S005 | Renata Medical, Inc. | PMA supplement | Dec 18, 2025 | FDA |
Minima Stent SystemP240003/S007 | Renata Medical, Inc. | PMA supplement | Feb 11, 2026 | FDA |
Minima Stent System; Minima Pro Stent SystemP240003/S008 | Renata Medical, Inc. | PMA supplement | Aug 27, 2026 | FDA |
Explore the linked device profile
Other records with product code PNF
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| NuMED, Inc. | PMA supplement | Jul 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Renata Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 4695 Macarthur Ct., Suite 1150, Newport Beach, CA, 92660
Sources and methodology
- Original FDA record: P240003/S006
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



